Abbott Laboratories (ABT) Interest Expenses (2009 - 2026)

Abbott Laboratories' Interest Expenses history runs 18 years deep, the most recent figure standing at $174.0 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 32.82% year-over-year to $174.0 million; the TTM figure through Mar 2026 stood at $536.0 million (down 2.37% YoY), while the FY2025 annual figure was $493.0 million, down 11.81% from the prior year.
• Interest Expenses came in at $174.0 million for Q1 2026 at Abbott Laboratories, up from $120.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $174.0 million in Q1 2026 to a low of $120.0 million in Q4 2025.
• A 5-year average of $142.4 million and a median of $141.0 million in 2022 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses slipped 14.79% in 2025 and surged 32.82% in 2026, its largest moves.
• Abbott Laboratories' Interest Expenses stood at $154.0 million in 2022, then climbed by 3.25% to $159.0 million in 2023, then decreased by 14.47% to $136.0 million in 2024, then slipped by 11.76% to $120.0 million in 2025, then soared by 45.0% to $174.0 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $174.0 million, $120.0 million, and $121.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison